Oligonucleotide-based gene therapy for cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Gene Therapy

Background:

• Cardiovascular diseases (CVDs) such as restenosis, graft occlusion, and familial hypercholesterolemia lack effective therapeutic options.
• Gene therapy presents a potential strategy for treating these challenging cardiovascular conditions.
• Efficient in vivo gene transfer is crucial for the success of gene therapy in cardiovascular applications.

Purpose of the Study:

• To review the future potential of oligonucleotide-based gene therapy for cardiovascular disease management.
• To highlight the emergence of gene therapy as a viable treatment strategy for specific cardiovascular disorders.

Main Methods:

• Review of existing literature on gene transfer technologies, including viral methods.
• Analysis of the molecular biology and pathophysiology of the cardiovascular system.
• Focus on oligonucleotide-based approaches for in vivo gene transfer.

Main Results:

• Numerous gene transfer methods, including viral techniques, have been developed over the past decade.
• Some gene transfer methods are currently being utilized in clinical human gene therapy studies.
• The convergence of molecular cardiovascular biology and pathophysiology supports the introduction of gene therapy.

Conclusions:

• Oligonucleotide-based gene therapy holds significant future potential for treating cardiovascular diseases.
• Gene therapy is poised to become an important tool in managing cardiovascular disorders, especially those with unmet therapeutic needs.